Daejeon, South Korea

Yun Hee Park

USPTO Granted Patents = 12 

 

Average Co-Inventor Count = 13.2

ph-index = 8

Forward Citations = 100(Granted Patents)


Location History:

  • Deajeon, KR (2023)
  • Daejeon, KR (2018 - 2024)

Company Filing History:


Years Active: 2018-2024

Loading Chart...
Loading Chart...
12 patents (USPTO):Explore Patents

Title: Innovations of Yun Hee Park

Introduction

Yun Hee Park is a prominent inventor based in Daejeon, South Korea. He has made significant contributions to the field of antibody-drug conjugates, holding a total of 12 patents. His work focuses on developing advanced therapeutic methods that enhance the efficacy of treatments.

Latest Patents

One of his latest patents involves antibody-drug conjugates comprising branched linkers. This invention relates to ADCs where multiple active agents are conjugated to an antibody through branched linkers. The branched linkers may include a branching unit, allowing for the coupling of two active agents via secondary linkers. Another notable patent focuses on anti-CD19 antibody drug conjugates, which details methods for linking active agents to an anti-CD19 antibody through a specialized linker. This innovation has potential applications in various therapeutic, diagnostic, and prophylactic areas.

Career Highlights

Yun Hee Park has worked with notable companies in the biotechnology sector, including Legochem Biosciences, Inc. and Novimmune SA. His experience in these organizations has contributed to his expertise in developing innovative therapeutic solutions.

Collaborations

Yun Hee Park has collaborated with several professionals in his field, including Yong Zu Kim and Jeiwook Chae. These collaborations have further enriched his research and development efforts.

Conclusion

Yun Hee Park's contributions to the field of antibody-drug conjugates demonstrate his commitment to advancing medical science. His innovative patents and collaborations highlight his role as a leading inventor in biotechnology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…